Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Knudson Insider Profile

4 Followers

Mark Knudson, former Chrmn, Pres & CEO, Director at ReShape Lifesciences, holds 675.17K shares in ReShape Lifesciences (Ticker: ~RSLS). Most recently, Mark Knudson Bought 310,000 shares of ReShape Lifesciences on Nov 16, 2015 for an estimated value of $49.60K.

Mark Knudson's Trading History

~RSLS
ReShape Lifesciences
Nov 16, 2015―Informative Buy49.60K$4.32M
~RSLS
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 16, 2015Informative Buy$49.60K310,000$0.16-97.80%
Aug 14, 2015Informative Buy$72.72K303,000$0.24-95.40%
Dec 10, 2010Informative Buy$43.50K25,000$1.74―
Feb 25, 2009Informative Buy$75.88K65,979$1.15―

You May Also Like

Mark Knudson insider profile FAQ

What is the percentage of profitable transactions made by Mark Knudson?
The percentage of profitable transactions made by Mark Knudson is 0%.
What is the average return per transaction made by Mark Knudson?
The average return per transaction made by Mark Knudson is -96.60%.
What stocks does Mark Knudson hold?
Mark Knudson holds: ~RSLS stocks.
What was Mark Knudson’s latest transaction?
Mark Knudson’s latest transaction was an Informative Buy of $49.60K.
What was Mark Knudson's most profitable transaction?
Mark Knudson’s most profitable transaction was an Informative Buy of ~RSLS stock on August 14, 2015. The return on the trade was -95.40%.
What is Mark Knudson's role in ReShape Lifesciences?
Mark Knudson's role in ReShape Lifesciences is Chrmn, Pres & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.